- Home
- VTAK vs CHNR Comparison
VTAK vs CHNR Comparison
Compare VTAK & CHNR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VTAK
- CHNR
- Stock Information
- Founded
- VTAK 2002
- CHNR N/A
- Country
- VTAK United States
- CHNR China
- Employees
- VTAK N/A
- CHNR N/A
- Industry
- VTAK Medical/Dental Instruments
- CHNR Precious Metals
- Sector
- VTAK Health Care
- CHNR Basic Materials
- Exchange
- VTAK Nasdaq
- CHNR Nasdaq
- Market Cap
- VTAK 3.9M
- CHNR 4.6M
- IPO Year
- VTAK 2018
- CHNR 1995
- Fundamental
- Price
- VTAK $3.04
- CHNR $3.70
- Analyst Decision
- VTAK
- CHNR
- Analyst Count
- VTAK 0
- CHNR 0
- Target Price
- VTAK N/A
- CHNR N/A
- AVG Volume (30 Days)
- VTAK 3.1M
- CHNR 76.0K
- Earning Date
- VTAK 08-11-2025
- CHNR 05-15-2025
- Dividend Yield
- VTAK N/A
- CHNR N/A
- EPS Growth
- VTAK N/A
- CHNR N/A
- EPS
- VTAK N/A
- CHNR N/A
- Revenue
- VTAK $600,000.00
- CHNR N/A
- Revenue This Year
- VTAK $822.86
- CHNR N/A
- Revenue Next Year
- VTAK $168.42
- CHNR N/A
- P/E Ratio
- VTAK N/A
- CHNR N/A
- Revenue Growth
- VTAK 37.62
- CHNR N/A
- 52 Week Low
- VTAK $2.49
- CHNR $3.16
- 52 Week High
- VTAK $43.70
- CHNR $9.04
- Technical
- Relative Strength Index (RSI)
- VTAK 44.02
- CHNR 51.27
- Support Level
- VTAK $2.70
- CHNR $3.41
- Resistance Level
- VTAK $4.31
- CHNR $3.68
- Average True Range (ATR)
- VTAK 0.37
- CHNR 0.22
- MACD
- VTAK 0.03
- CHNR 0.04
- Stochastic Oscillator
- VTAK 30.22
- CHNR 80.60
About VTAK Catheter Precision Inc.
Catheter Precision Inc is engaged in design, manufacture and sale of new and innovative medical technologies primarily focused in the field of cardiac electrophysiology, or EP. The Company's primary product is the View into Ventricular Onset System (VIVO or VIVO System), which is a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. The VIVO system has achieved a CE Mark allowing it to be commercialized in the European Union and has been placed at several hospitals in Europe. Its newest product, the Surgical Vessel Closing Pressure Device (LockeT), is a suture retention device indicated for wound healing by distributing suture tension.
About CHNR China Natural Resources Inc.
China Natural Resources Inc is engaged in exploration for lead, silver, and other metals in the Inner Mongolia Autonomous Region of the PRC and exploration of attractive opportunities in other sectors. The company has a single operating segment: exploration and mining.